There are 3162 resources available
1942O - Application of GigaPath: An open-weight billion-parameter AI foundation model based on a novel vision transformer architecture for cancer mutation prediction and TME analysis
Presenter: Carlo Bifulco
Session: Presidential Symposium III: Eyes to the future
Resources:
Abstract
Slides
Webcast
Targeting the DNA damage response
Presenter: Magnus Dillon
Session: New therapeutic approaches in concomitant chemoradiotherapy
Resources:
Slides
Webcast
Invited Discussant LBA7 and 1942O: Moving towards molecular and AI-driven oncology
Presenter: Federica Di Nicolantonio
Session: Presidential Symposium III: Eyes to the future
Resources:
Slides
Webcast
Oncogene-addicted earlier stage NSCLC: Current standards, debates, and open questions
Presenter: Laura Mezquita
Session: Promises and pitfalls in earlier stage NSCLC
Resources:
Slides
Webcast
Gastric NEN: When to recommend radical surgery?
Presenter: José Díaz Tasende
Session: Controversies in the management and follow up of small localised neuroendocrine tumours
Resources:
Slides
Webcast
Targeting innate immune signalling pathways
Presenter: Sara Pai
Session: New therapeutic approaches in concomitant chemoradiotherapy
Resources:
Slides
Webcast
The role of radiotherapy in earlier stage NSCLC
Presenter: Suresh Senan
Session: Promises and pitfalls in earlier stage NSCLC
Resources:
Slides
Webcast
Pancreatic NEN: Watchful wait vs radical surgery
Presenter: Massimo Falconi
Session: Controversies in the management and follow up of small localised neuroendocrine tumours
Resources:
Slides
Webcast
509O - Total neoadjuvant treatment (TNT) with non-operative management (NOM) for proficient mismatch repair locally advanced rectal cancer (pMMR LARC): First results of NO-CUT trial
Presenter: Alessio Amatu
Session: Presidential Symposium III: Eyes to the future
Resources:
Abstract
Slides
Webcast
Discussion
Session: Controversies in the management and follow up of small localised neuroendocrine tumours
Resources:
Webcast